Agile Therapeutics
AGRX
#10315
Rank
C$14.22 M
Marketcap
C$2.06
Share price
0.00%
Change (1 day)
288.75%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -C$20.4 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are C$21.56 Million. In 2023 the company made an earning of -C$17.8 Million a decrease over its 2022 earnings that were of -C$6.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$20.4 Million14.58%
2023 -C$17.8 Million172.57%
2022 -C$6.53 Million-93.26%
2021 -C$96.82 Million45.62%
2020 -C$66.49 Million161.98%
2019 -C$25.38 Million-2.78%
2018 -C$26.11 Million-27.47%
2017 -C$36 Million-10.16%
2016 -C$40.06 Million-14.2%
2015 -C$46.7 Million88.45%
2014 -C$24.78 Million41.72%
2013 -C$17.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.18 B-215,699.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.16 B-78,976.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.49 B-153,766.98%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
C$0.01 M-100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$89.86 M-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA